New Jersey Poison Control Warns Somerset of Suspected Patient Poisonings

New Jersey Poison Control Warns Somerset of Suspected Patient Poisonings is the escalating confrontation between Bruce Ruck and Steven Marcus of New Jersey Poison Control and the administration of Somerset Medical Center over patients suffering unexplained episodes consistent with poisoning. As laboratory findings and repeated clinical crises narrowed the plausible explanations, Ruck and Marcus argued that the hospital could not investigate privately at its own pace: suspected criminal harm required police involvement, and suspected patient poisonings had to be reported. The warning becomes a contest over both patient safety and authority—who gets to define the events, and who is obliged to act.

A clinical pattern becomes a possible crime

The concern was not based on a single unexplained collapse. At Somerset, patients had experienced severe hypoglycemic episodes, and testing of two patients showed high insulin levels without C-peptide. That combination mattered because the patients’ bodies were not producing the insulin found in their blood. Ruck explained the implication to Nancy Doherty: if the patients had high insulin and no C-peptide, someone had given them insulin. The laboratory result did not by itself identify who was responsible, but it made an ordinary explanation harder to sustain.

The evidence also carried a practical warning: insulin was not an obscure substance whose presence would automatically establish wrongdoing. Somerset’s administration could still consider error, interactions, or other explanations, but the unexplained results needed investigation beyond the hospital’s own clinical review. The issue was not merely whether patients had become ill; it was whether someone had deliberately caused their illness while they were under hospital care.

The warning and the institutional standoff

On July 8, 2003, a conference call was arranged for nine in the morning after increasingly heated calls from Marcus. It was Mary Lund’s second conversation with him. This time, Marcus addressed Somerset administrators directly, arguing that if someone was purposely harming patients, the hospital had a legal obligation to report it. His concern was sharpened by the danger of delay: an internal inquiry might consume time while additional patients remained exposed.

Ruck distilled the dispute into a repeated point: this was a police matter. Marcus agreed, and urged Somerset to bring its legal representatives into the process without letting that step become a reason to postpone notifying authorities. He had seen previous cases in which hospitals treated clusters of collapsing patients as medical puzzles while administrators and lawyers treated them as potential lawsuits. In those cases, the delay before police involvement could allow a suspected employee to move on and make the investigation harder. Marcus recognized the same risk in Somerset’s response.

Somerset did not immediately accept the distinction between internal investigation and outside reporting. A day after Ruck and Marcus were still waiting for a callback, Ruck again contacted the hospital pharmacy and spoke with Stuart Vigdor, the head of pharmacy and Doherty’s supervisor. Vigdor said that the administration had taken over the investigation. That answer made the institutional conflict explicit: Poison Control was urging external action, while Somerset retained control of the inquiry and had not yet reported the incidents.

Escalation beyond the hospital

In a later conference call, Marcus again told the administrators that suspected patient harm had to be reported to the state within twenty-four hours and that Somerset was already out of compliance. The hospital maintained that it would wait until it had completed a thorough internal investigation before contacting either the New Jersey Department of Health and Senior Services or police. Marcus responded with unusual force. He described himself as extremely concerned and frustrated, and his manner was later characterized by one administrator as rude, confrontational, and adversarial. His anger was not simply a personal clash: he was insisting that patient safety and the reporting duty could not be subordinated to the hospital’s preferred timetable.

The warning also contained an important reversal. Marcus told Somerset that he would report the matter to the health department if the hospital did not act, but he had already contacted state health officials earlier that afternoon. He described a cluster of illnesses that might have resulted from a criminal act and sent a written account of four untoward clinical events, along with Somerset’s unwillingness to report them before completing its own investigation. Twenty minutes into the call, he disclosed that the conversations had been recorded. The recordings preserved the conflict over what Somerset had been told, what it had agreed to do, and how long it had waited.

A few hours later, Lund reported the four patient incidents to the state by fax and email: Reverend Florian Gall and Jin Kyung Han had experienced digoxin incidents, while the other two cases involved insulin. The report described checks Somerset had already undertaken. Staff had investigated possible manufacturer recalls and adverse drug interactions, checked that intravenous equipment and bedside monitors were functioning accurately, and repeated laboratory tests to rule out lab error. The hospital was running out of alternative explanations. It tightened controls on digoxin, as it had on insulin, making nurses accountable for these commonly used drugs in case access to them had been used to harm patients.

Consequences and significance

The warning did not itself establish who had poisoned the patients or resolve the investigation. It did force the reporting dispute into the open and help move information beyond the hospital. The later police inquiry reached Amy Loughren, who had initially resisted involvement and feared the consequences of being associated with the investigation. When Danny Baldwin showed her a Pyxis printout from the night Reverend Gall died, she recognized Charles Cullen’s medication activity and could no longer dismiss the possibility that her friend had done something terrible. The report had become more than an argument between administrators and Poison Control: it was part of the evidentiary trail that challenged the trust surrounding Cullen.

The pressure also changed the meaning of Somerset’s internal precautions. Tightened controls on insulin and digoxin could reduce access, but they could not substitute for prompt reporting or an independent criminal investigation. The contrast between the hospital’s insistence on completing its own inquiry first and Poison Control’s insistence on immediate outside scrutiny is central to the event. The warning frames delay not as a neutral administrative choice but as a risk borne by patients, while recorded calls and state notification begin to create a record that an internal process alone could not control.